Global Granisetron Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 100

Report ID: 4362

Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata.
In 2018, the global Granisetron market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Granisetron status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Granisetron development in United States, Europe and China.

The key players covered in this study
Kyowa Kirin
Heron Therapeutics
Fresenius Kabi
Hikma Pharmaceuticals
Teva
Cipla
Sandoz
Wockhardt
Mylan
APOTEX
Dr.Reddy's
Bluepharma
Natco Pharma
Akorn
Taro Pharmaceutical
Aurobindo

Market segment by Type, the product can be split into
Transdermal system
Injection
Oral

Market segment by Application, split into
Chemotherapy
Post operative

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Granisetron status, future forecast, growth opportunity, key market and key players.
To present the Granisetron development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Granisetron are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Granisetron Market Size Growth Rate by Type (2014-2025)
1.4.2 Transdermal system
1.4.3 Injection
1.4.4 Oral
1.5 Market by Application
1.5.1 Global Granisetron Market Share by Application (2014-2025)
1.5.2 Chemotherapy
1.5.3 Post operative
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Granisetron Market Size
2.2 Granisetron Growth Trends by Regions
2.2.1 Granisetron Market Size by Regions (2014-2025)
2.2.2 Granisetron Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Granisetron Market Size by Manufacturers
3.1.1 Global Granisetron Revenue by Manufacturers (2014-2019)
3.1.2 Global Granisetron Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Granisetron Market Concentration Ratio (CR5 and HHI)
3.2 Granisetron Key Players Head office and Area Served
3.3 Key Players Granisetron Product/Solution/Service
3.4 Date of Enter into Granisetron Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Granisetron Market Size by Type (2014-2019)
4.2 Global Granisetron Market Size by Application (2014-2019)

5 United States
5.1 United States Granisetron Market Size (2014-2019)
5.2 Granisetron Key Players in United States
5.3 United States Granisetron Market Size by Type
5.4 United States Granisetron Market Size by Application

6 Europe
6.1 Europe Granisetron Market Size (2014-2019)
6.2 Granisetron Key Players in Europe
6.3 Europe Granisetron Market Size by Type
6.4 Europe Granisetron Market Size by Application

7 China
7.1 China Granisetron Market Size (2014-2019)
7.2 Granisetron Key Players in China
7.3 China Granisetron Market Size by Type
7.4 China Granisetron Market Size by Application

8 Japan
8.1 Japan Granisetron Market Size (2014-2019)
8.2 Granisetron Key Players in Japan
8.3 Japan Granisetron Market Size by Type
8.4 Japan Granisetron Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Granisetron Market Size (2014-2019)
9.2 Granisetron Key Players in Southeast Asia
9.3 Southeast Asia Granisetron Market Size by Type
9.4 Southeast Asia Granisetron Market Size by Application

10 India
10.1 India Granisetron Market Size (2014-2019)
10.2 Granisetron Key Players in India
10.3 India Granisetron Market Size by Type
10.4 India Granisetron Market Size by Application

11 Central & South America
11.1 Central & South America Granisetron Market Size (2014-2019)
11.2 Granisetron Key Players in Central & South America
11.3 Central & South America Granisetron Market Size by Type
11.4 Central & South America Granisetron Market Size by Application

12 International Players Profiles
12.1 Kyowa Kirin
12.1.1 Kyowa Kirin Company Details
12.1.2 Company Description and Business Overview
12.1.3 Granisetron Introduction
12.1.4 Kyowa Kirin Revenue in Granisetron Business (2014-2019)
12.1.5 Kyowa Kirin Recent Development
12.2 Heron Therapeutics
12.2.1 Heron Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Granisetron Introduction
12.2.4 Heron Therapeutics Revenue in Granisetron Business (2014-2019)
12.2.5 Heron Therapeutics Recent Development
12.3 Fresenius Kabi
12.3.1 Fresenius Kabi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Granisetron Introduction
12.3.4 Fresenius Kabi Revenue in Granisetron Business (2014-2019)
12.3.5 Fresenius Kabi Recent Development
12.4 Hikma Pharmaceuticals
12.4.1 Hikma Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Granisetron Introduction
12.4.4 Hikma Pharmaceuticals Revenue in Granisetron Business (2014-2019)
12.4.5 Hikma Pharmaceuticals Recent Development
12.5 Teva
12.5.1 Teva Company Details
12.5.2 Company Description and Business Overview
12.5.3 Granisetron Introduction
12.5.4 Teva Revenue in Granisetron Business (2014-2019)
12.5.5 Teva Recent Development
12.6 Cipla
12.6.1 Cipla Company Details
12.6.2 Company Description and Business Overview
12.6.3 Granisetron Introduction
12.6.4 Cipla Revenue in Granisetron Business (2014-2019)
12.6.5 Cipla Recent Development
12.7 Sandoz
12.7.1 Sandoz Company Details
12.7.2 Company Description and Business Overview
12.7.3 Granisetron Introduction
12.7.4 Sandoz Revenue in Granisetron Business (2014-2019)
12.7.5 Sandoz Recent Development
12.8 Wockhardt
12.8.1 Wockhardt Company Details
12.8.2 Company Description and Business Overview
12.8.3 Granisetron Introduction
12.8.4 Wockhardt Revenue in Granisetron Business (2014-2019)
12.8.5 Wockhardt Recent Development
12.9 Mylan
12.9.1 Mylan Company Details
12.9.2 Company Description and Business Overview
12.9.3 Granisetron Introduction
12.9.4 Mylan Revenue in Granisetron Business (2014-2019)
12.9.5 Mylan Recent Development
12.10 APOTEX
12.10.1 APOTEX Company Details
12.10.2 Company Description and Business Overview
12.10.3 Granisetron Introduction
12.10.4 APOTEX Revenue in Granisetron Business (2014-2019)
12.10.5 APOTEX Recent Development
12.11 Dr.Reddy's
12.12 Bluepharma
12.13 Natco Pharma
12.14 Akorn
12.15 Taro Pharmaceutical
12.16 Aurobindo

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details